Monthly injections of tonlamarsen lowered AGT but didn’t reduce BP in patients already on multiple antihypertensive drugs.

Teva’s biosimilar, PONLIMSI™, is now FDA-approved across all indications of the reference product, Prolia ® (denosumab), to treat a variety of ...

Tonlamarsen “suppresses hepatic angiotensinogen production,” Laffin told the media ahead of the late-breaking session. “We know that AGT suppression reduces blood pressure among patients taking zero ...

A small device implanted just beneath the skin, roughly the size of a large postage stamp and weighing about two grams, kept ...

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced new clinical and real-world data from its cardiovascular (CV) portfolio presented at the American ...

USA: A small study published in Obesity found that some patients using GLP-1 weight-loss medications were able to sustain ...

Mass General Brigham researchers found that the intensive cholesterol-lowering therapy evolocumab reduced the risk of a first major cardiovascular event in high-risk patients who did not have known ...

Japan MHLW grants marketing authorization to Bayer’s Eylea 8 mg to treat patients with macular edema following RVO: Berlin Tuesday, March 24, 2026, 13:00 Hrs [IST] The Ministry ...

Earlier use of cholesterol lowring drug evolocumab may reduce heart attack and stroke risk in high-risk diabetes patients without known heart disease.

Good eye health goes far beyond simply buying a new pair of glasses. This is something that optometrists at Specsavers are more than aware of, having spent years referring patients with suspected eye ...

Zombie filler’, or using cadaver tissue that’s been sterilized and branded as Alloclae, is the latest cosmetic surgery rage. Is it safe?

Ophthalmology pioneered the clinical use of artificial intelligence (AI). Beyond automating routine tasks, including retinal ...